A Novel Molecular-Based Diagnostic Screening Test Utilizing the NanoCHIP® Microarray Technology for Simultaneous Detection of Major STI’s

22 May 2014

Sexually transmitted infections (STI) are widely abundant all over the world, and there is a need for detection of early stages of STIs is in order to control and prevent these diseases. This study, presented at ECCMID 2014, demonstrates the utility of a newly developed test for screening purposes of STIs especially in high-risk populations.

NanoCHIP® XL Analyzer

Savyon Diagnostics

The NanoChip® system is an automated, multi-purpose instrument which is used for clinical molecular diagnostics. Clinical microbiology, genetics/cytogenetics and pathology laboratories use this convenient platform to identify pathogenic infections, carriage of genetic disorders, predisposition to diseases and response to pharmaceutical therapies. The NanoCHIP® technology is intended for those users that require: Medium-to high throughput Multiplex molecular testing (over 4 markers/sample) Automation Simplicity Full LIS connectivity

(0)

Links

Tags

A Novel Molecular-Based Diagnostic Screening Test Utilizing the NanoCHIP® Microarray Technology for Simultaneous Detection of Major STI’s